A. James Mason

3.9k total citations
87 papers, 3.0k citations indexed

About

A. James Mason is a scholar working on Molecular Biology, Microbiology and Ecology. According to data from OpenAlex, A. James Mason has authored 87 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 40 papers in Microbiology and 8 papers in Ecology. Recurrent topics in A. James Mason's work include Antimicrobial Peptides and Activities (36 papers), RNA Interference and Gene Delivery (22 papers) and Lipid Membrane Structure and Behavior (15 papers). A. James Mason is often cited by papers focused on Antimicrobial Peptides and Activities (36 papers), RNA Interference and Gene Delivery (22 papers) and Lipid Membrane Structure and Behavior (15 papers). A. James Mason collaborates with scholars based in United Kingdom, France and Hong Kong. A. James Mason's co-authors include Burkhard Bechinger, Antoine Kichler, Arnaud Marquette, Alex F. Drake, Jenny K.W. Lam, Clemens Glaubitz, Tam T. T. Bui, Gideon M. Henderson, Anthony Watts and Tokuwa Kanno and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

A. James Mason

85 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. James Mason United Kingdom 36 1.8k 1.0k 296 277 252 87 3.0k
Jeffrey L. Fox United States 37 2.2k 1.2× 389 0.4× 81 0.3× 190 0.7× 296 1.2× 411 4.9k
Vernita Gordon United States 31 1.9k 1.1× 459 0.5× 65 0.2× 189 0.7× 92 0.4× 69 3.4k
Michãel Palmer Canada 36 2.3k 1.3× 629 0.6× 819 2.8× 33 0.1× 528 2.1× 103 4.8k
Sakae Tsuda Japan 35 1.4k 0.7× 115 0.1× 449 1.5× 178 0.6× 137 0.5× 117 3.3k
Thomas Boesen Denmark 27 1.2k 0.7× 141 0.1× 134 0.5× 103 0.4× 392 1.6× 94 2.8k
Raz Zarivach Israel 36 4.7k 2.6× 141 0.1× 203 0.7× 160 0.6× 231 0.9× 124 6.2k
Stephen A. Holt Australia 32 1.1k 0.6× 226 0.2× 32 0.1× 254 0.9× 69 0.3× 116 3.1k
Stéphane M. Gagné Canada 30 1.6k 0.9× 73 0.1× 160 0.5× 193 0.7× 110 0.4× 66 3.0k
Daisuke Takahashi Japan 34 1.8k 1.0× 309 0.3× 40 0.1× 96 0.3× 311 1.2× 219 3.8k
Jiayan Wu China 31 2.0k 1.1× 89 0.1× 121 0.4× 63 0.2× 135 0.5× 119 3.5k

Countries citing papers authored by A. James Mason

Since Specialization
Citations

This map shows the geographic impact of A. James Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. James Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. James Mason more than expected).

Fields of papers citing papers by A. James Mason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. James Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. James Mason. The network helps show where A. James Mason may publish in the future.

Co-authorship network of co-authors of A. James Mason

This figure shows the co-authorship network connecting the top 25 collaborators of A. James Mason. A scholar is included among the top collaborators of A. James Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. James Mason. A. James Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barron, Leon, et al.. (2025). Biochar filtration of drug-resistant bacteria and active pharmaceutical ingredients to combat antimicrobial resistance. Scientific Reports. 15(1). 1256–1256. 5 indexed citations
2.
Zain, Nur Masirah M., Blair Merrick, Lindsey Edwards, et al.. (2025). Bacterial diversity, viability and stability in lyophilised faecal microbiota capsules support ongoing clinical use. International Journal of Pharmaceutics. 678. 125703–125703. 1 indexed citations
3.
Oosthuizen, Carel B., et al.. (2025). Enhanced Gram-Negative Membrane Disruption and In Vivo Efficacy via Lysine-Arginine Enrichment of Opis16a. ACS Medicinal Chemistry Letters. 16(6). 998–1007.
4.
Hind, Charlotte K., et al.. (2025). Metabolism of Lactobacillus and Gardnerella vaginalis in vaginal defined media. Anaerobe. 95. 102991–102991.
5.
Hind, Charlotte K., Guilherme Fernandes, Melanie Clifford, et al.. (2024). Development of Novel Membrane Disrupting Lipoguanidine Compounds Sensitizing Gram-Negative Bacteria to Antibiotics. ACS Medicinal Chemistry Letters. 15(2). 239–249. 1 indexed citations
6.
Hind, Charlotte K., Melanie Clifford, J. Mark Sutton, et al.. (2024). QSAR Reveals Decreased Lipophilicity of Polar Residues Determines the Selectivity of Antimicrobial Peptide Activity. ACS Omega. 9(24). 26030–26049. 7 indexed citations
7.
Mason, A. James, et al.. (2024). Emergent conformational and aggregation properties of synergistic antimicrobial peptide combinations. Nanoscale. 16(44). 20657–20669. 2 indexed citations
8.
Hind, Charlotte K., Giorgia Manzo, Melanie Clifford, et al.. (2023). Synergy between Winter Flounder antimicrobial peptides. PubMed. 1(1). 8–8. 7 indexed citations
9.
Centelles, Miguel N., et al.. (2023). Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake. Molecular Pharmaceutics. 20(5). 2341–2351. 6 indexed citations
10.
Manzo, Giorgia, Charlotte K. Hind, Melanie Clifford, et al.. (2022). Temporin B Forms Hetero-Oligomers with Temporin L, Modifies Its Membrane Activity, and Increases the Cooperativity of Its Antibacterial Pharmacodynamic Profile. Biochemistry. 61(11). 1029–1040. 7 indexed citations
11.
Bock, Lucy J., et al.. (2021). Pseudomonas aeruginosa adapts to octenidine via a combination of efflux and membrane remodelling. Communications Biology. 4(1). 1058–1058. 19 indexed citations
12.
Qiu, Yingshan, et al.. (2021). Optimization of PEGylated KL4 Peptide for siRNA Delivery with Improved Pulmonary Tolerance. Molecular Pharmaceutics. 18(6). 2218–2232. 13 indexed citations
13.
Edwards, Cathrina H., et al.. (2021). α-Amylase action on starch in chickpea flour following hydrothermal processing and different drying, cooling and storage conditions. Carbohydrate Polymers. 259. 117738–117738. 22 indexed citations
14.
Manzo, Giorgia, Charlotte K. Hind, Roland A. Fleck, et al.. (2021). Impacts of Metabolism and Organic Acids on Cell Wall Composition and Pseudomonas aeruginosa Susceptibility to Membrane Active Antimicrobials. ACS Infectious Diseases. 7(8). 2310–2323. 8 indexed citations
15.
Manzo, Giorgia, Charlotte K. Hind, Melanie Clifford, et al.. (2019). Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity. Scientific Reports. 9(1). 1385–1385. 25 indexed citations
16.
Manzo, Giorgia, Charlotte K. Hind, Melanie Clifford, et al.. (2019). Temporin L and aurein 2.5 have identical conformations but subtly distinct membrane and antibacterial activities. Scientific Reports. 9(1). 10934–10934. 30 indexed citations
17.
18.
Wang, Yanan, Lex E. X. Leong, Tokuwa Kanno, et al.. (2018). Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut. Gut Microbes. 10(3). 367–381. 41 indexed citations
19.
Lan, Yun, Jason T. Lam, G. G. Siu, et al.. (2014). Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant Mycobacterium tuberculosis. Tuberculosis. 94(6). 678–689. 46 indexed citations
20.
Abbate, Vincenzo, Wanling Liang, Yun Lan, et al.. (2013). Manipulating the pH response of 2,3-diaminopropionic acid rich peptides to mediate highly effective gene silencing with low-toxicity. Journal of Controlled Release. 172(3). 929–938. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey L. Fox Breakdown of academic impact, for papers by Vernita Gordon Breakdown of academic impact, for papers by Michãel Palmer Breakdown of academic impact, for papers by Sakae Tsuda Breakdown of academic impact, for papers by Thomas Boesen Breakdown of academic impact, for papers by Raz Zarivach Breakdown of academic impact, for papers by Stephen A. Holt Breakdown of academic impact, for papers by Stéphane M. Gagné Breakdown of academic impact, for papers by Daisuke Takahashi Breakdown of academic impact, for papers by Jiayan Wu
Rankless by CCL
2026